PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $489,000 | +14.3% | 11,250 | 0.0% | 0.72% | +24.8% |
| Q1 2019 | $428,000 | -11.6% | 11,250 | 0.0% | 0.58% | -45.5% |
| Q4 2018 | $484,000 | -12.5% | 11,250 | 0.0% | 1.06% | -19.3% |
| Q3 2018 | $553,000 | +37.9% | 11,250 | -10.0% | 1.32% | +51.7% |
| Q2 2018 | $401,000 | +3.1% | 12,500 | 0.0% | 0.87% | +14.0% |
| Q1 2018 | $389,000 | -65.9% | 12,500 | -50.0% | 0.76% | -22.7% |
| Q4 2017 | $1,141,000 | +21.5% | 25,000 | 0.0% | 0.99% | +17.2% |
| Q3 2017 | $939,000 | -21.3% | 25,000 | 0.0% | 0.84% | -23.0% |
| Q2 2017 | $1,193,000 | -47.7% | 25,000 | -50.0% | 1.09% | -35.4% |
| Q1 2017 | $2,280,000 | +41.2% | 50,000 | 0.0% | 1.69% | +31.5% |
| Q4 2016 | $1,615,000 | -5.6% | 50,000 | 0.0% | 1.29% | +34.2% |
| Q3 2016 | $1,711,000 | -8.0% | 50,000 | +42.4% | 0.96% | -33.3% |
| Q1 2016 | $1,860,000 | +26.8% | 35,110 | +83.7% | 1.44% | +48.4% |
| Q4 2015 | $1,467,000 | +70.0% | 19,110 | -9.0% | 0.97% | +103.1% |
| Q3 2015 | $863,000 | -74.0% | 21,000 | -55.3% | 0.48% | -81.9% |
| Q2 2015 | $3,324,000 | +7.1% | 47,000 | +34.5% | 2.63% | +1.2% |
| Q1 2015 | $3,105,000 | – | 34,949 | – | 2.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |